Select from the list of Treatises products below:
Your one-stop resource to help you with the ever-changing health care fraud and abuse laws & regulations.
For any organization or individual conducting clinical research studies, the Clinical Research Compliance Manual: An Administrative Guide covers today's most crucial topics, including: Human subject protections; Institutional Review Board regulations and requirements; Conflicts of interest; Scientific misconduct; Reimbursement issues;
An Attorney’s Guide is your one-stop resource to help you with the ever-changing health care fraud and abuse laws & regulations.
A practical guide for health care providers that explains fraud and abuse laws in plain language, using examples to illustrate the principles.
The how-to, practical guide to health care risk management.
Brings you the latest information on emerging issues in health law and health care compliance. Each chapter is authored by an expert in the area and includes in-depth analysis of the latest health law and compliance issues.
Easy-to-understand explanations of the legal and regulatory aspects of HIPAA.
Provides you with the guidance you need on every issue pertinent to health care facilities.
Expert, current know-how for dealing with hundreds of hospitals contracts scenarios.
The authoritative guide to COBRA issues facing emergency department physicians, specialists and hospitals.
News Headlines |
Top Sellers
|
||
Topic SpotlightOIG refines self-disclosure protocol requirements Providers that make appropriate disclosures under the Office of Inspector General's (OIG's) self-disclosure protocol (SDP) will have the benefit of a presumption against imposition of corporate integrity agreements (CIAs) and certification of compliance agreements (CCAs), according to an open letter to health care providers issued by Inspector General Daniel R. Levinson on April 15, 2008. The letter, which refines the requirements for participation in the SDP, "emphasizes the Office of Inspector General's (OIG's) commitment to streamline its internal process for self-disclosure case resolution," the OIG said in a related press release. Learn More » |
|||
In Focus
|
|||
